Zohar Levy

566 total citations
10 papers, 428 citations indexed

About

Zohar Levy is a scholar working on Surgery, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Zohar Levy has authored 10 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Surgery, 2 papers in Nephrology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Zohar Levy's work include Chronic Kidney Disease and Diabetes (2 papers), Cytokine Signaling Pathways and Interactions (1 paper) and Retinal Imaging and Analysis (1 paper). Zohar Levy is often cited by papers focused on Chronic Kidney Disease and Diabetes (2 papers), Cytokine Signaling Pathways and Interactions (1 paper) and Retinal Imaging and Analysis (1 paper). Zohar Levy collaborates with scholars based in Israel and Canada. Zohar Levy's co-authors include Rita Rachmani, Mordchai Ravid, David Brosh, Merav Lidar, Joshua Weissgarten, Aviv Shaish, Zhan Averbukh, David Modai, Svetlana Trestman and Hofit Cohen and has published in prestigious journals such as BMC Cancer, Molecular Metabolism and European Journal of Internal Medicine.

In The Last Decade

Zohar Levy

9 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zohar Levy Israel	6	197	186	109	65	42	10	428
Mai Ots Estonia	13	269 1.4×	91 0.5×	228 2.1×	82 1.3×	77 1.8×	19	579
J. Chahin Spain	9	311 1.6×	94 0.5×	62 0.6×	60 0.9×	48 1.1×	14	445
S Yeung Australia	8	99 0.5×	136 0.7×	77 0.7×	50 0.8×	48 1.1×	9	365
T. Strand United States	7	271 1.4×	274 1.5×	250 2.3×	66 1.0×	73 1.7×	8	783
Ander Vergara Spain	13	157 0.8×	174 0.9×	96 0.9×	115 1.8×	111 2.6×	22	519
Nobue Tanaka Japan	12	154 0.8×	157 0.8×	100 0.9×	62 1.0×	76 1.8×	29	454
Jaap A. Joles Netherlands	8	105 0.5×	178 1.0×	87 0.8×	93 1.4×	84 2.0×	11	428
Sho Kinguchi Japan	15	132 0.7×	146 0.8×	155 1.4×	88 1.4×	113 2.7×	51	538
K. N�rgaard Denmark	8	165 0.8×	202 1.1×	108 1.0×	89 1.4×	50 1.2×	9	423
S-L Wang China	8	64 0.3×	179 1.0×	111 1.0×	95 1.5×	96 2.3×	26	513

Countries citing papers authored by Zohar Levy

Since Specialization

Citations

This map shows the geographic impact of Zohar Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zohar Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zohar Levy more than expected).

Fields of papers citing papers by Zohar Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zohar Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zohar Levy. The network helps show where Zohar Levy may publish in the future.

Co-authorship network of co-authors of Zohar Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Zohar Levy. A scholar is included among the top collaborators of Zohar Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zohar Levy. Zohar Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Levy, Zohar, et al.. (2025). A18 EXPLORING TRAINED IMMUNITY IN INTESTINAL EPITHELIAL CELLS DURING TYPE 2 IMMUNE RESPONSES. Journal of the Canadian Association of Gastroenterology. 8(Supplement_1). i8–i8.

2.

Vieira, Sílvia Regina Rios, et al.. (2025). Fructose-induced synaptic and neuronal adaptations at neuropeptide Y/agouti-related peptide neurons. Molecular Metabolism. 99. 102209–102209. 1 indexed citations

3.

Margel, David, Ofer Benjaminov, Inbal Kedar, et al.. (2014). Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study. BMC Cancer. 14(1). 528–528. 5 indexed citations

4.

Y, Niv, et al.. (2006). [Colonoscopy for early detection of colorectal cancer in average-risk population].. PubMed. 145(11). 841–2. 2 indexed citations

5.

Rachmani, Rita, et al.. (2004). Use of a mild sedative helps to identify true non-dippers by ABPM: a study in patients with diabetes mellitus and hypertension. Blood Pressure Monitoring. 9(2). 65–69. 11 indexed citations

6.

Levy, Zohar, Aviv Shaish, Svetlana Trestman, et al.. (2003). Omapatrilat, an Angiotensin‐Converting Enzyme and Neutral Endopeptidase Inhibitor, Attenuates EarlyAtherosclerosis in Diabetic and in Nondiabetic Low‐Density Lipoprotein Receptor–Deficient Mice. Journal of Diabetes Research. 4(1). 59–64. 7 indexed citations

7.

Levy, Zohar. (2003). Low-dose interferon-α accelerates atherosclerosis in an LDL receptor-deficient mouse model. European Journal of Internal Medicine. 14(8). 479–483. 34 indexed citations

8.

Weissgarten, Joshua, et al.. (2001). Vitamin B<sub>6</sub> Therapy Does Not Improve Hematocrit in Hemodialysis Patients Supplemented with Iron and Erythropoietin. The Nephron journals/Nephron journals. 87(4). 328–332. 7 indexed citations

9.

Rachmani, Rita, Merav Lidar, Zohar Levy, & Mordchai Ravid. (2000). Effect of enalapril on the incidence of retinopathy in normotensive patients with type 2 diabetes. European Journal of Internal Medicine. 11(1). 48–50. 6 indexed citations

10.

Ravid, Mordchai, et al.. (1998). Main Risk Factors for Nephropathy in Type 2 Diabetes Mellitus Are Plasma Cholesterol Levels, Mean Blood Pressure, and Hyperglycemia. Archives of Internal Medicine. 158(9). 998–998. 355 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact